Pharma in MOTION - Day 4: Biophysical Characterization

Methodology. Optimization. Technology. Innovation. Operations. Networking. These are the core capabilities that ensure your lab remains at the forefront of pharmaceutical history.

Join Waters and our panel of industry experts for this special, first edition of Pharma in MOTION . Over the course of this four-day virtual event we will discuss the unique challenges our trade faces and share potential problem-solving solutions. This is your chance to connect and brainstorm with some of the brightest minds in the scientific community.

Hear from our speakers as they present how to:

• Accelerate peptide multi-attribute method (MAM) analysis through purpose-built workflows
• Increase productivity in pharmaceutical analysis using mass detection
• Use various technologies to solve your biggest pharmaceutical challenges

Day 4: Biophysical Characterization

16:00 – 10:10 CEST: Welcome and Housekeeping

• Presenter: Guillaume Béchade (Marketing Manager, Biopharmaceuticals, Waters Corporation)

16:10 – 16:20 CEST: SARS-CoV-2 Therapeutic mAb Development Using HDX-MS

• Presenter: Deepa Balasubrimaniam (Senior Research Scientist, Eli Lilly)

16:20 –16:40 CEST: Uncovering Virus Breathing Dynamics by Mass Spectrometry

• Presenter: Ganesh Anand (Associate Professor, Penn State University)

16:40 – 17:00 CEST: Hydrogen–Deuterium Exchange Coupled with (Cyclic) Ion Mobility MS for Higher Quality Analyses

• Presenter: Malcolm Anderson (Principal Application Chemist, Waters Corporation)

17:00 –17:20 CEST: Isothermal Titration Calorimetry as a Tool to Study the Interactions of Ligands and Drugs with SARS-CoV-2 Proteins

• Presenter: David Frick (Professor, University of Wisconsin)

17:20 – 18:00 CEST: Live Panel Q&A Session

• Presenter: Hosted by John Engen (Professor of Chemistry & Chemical Biology, Northeastern University)